
To investigate the efficacy and safety of three doses of zzso and determine the minimum effective dose for zzso zzso of the central nervous system zzso 

This was a Phase II, zzso zzso zzso controlled study in subjects referred for zzso zzso of the zzso zzso were zzso to receive zzso zzso zzso or zzso body weight, and underwent zzso zzso and zzso zzso zzso Three blinded readers assessed the zzso zzso efficacy variables were number of zzso zzso border zzso contrast enhancement, and internal zzso 

Of the 229 zzso subjects, 173 were evaluated for zzso zzso meaningful improvements in zzso border zzso contrast enhancement, and internal zzso were observed for zzso zzso zzso comparisons of a composite score of the four primary variables showed the zzso dose to be statistically superior to the zzso dose zzso The zzso dose showed no statistically significant difference with the zzso zzso Twenty-two zzso subjects reported at least one zzso adverse event zzso No zzso was reported at an zzso zzso 

The zzso dose of zzso was effective and well tolerated for zzso zzso of the zzso 

